B3GNT2 and neoplasm: For T cell proteins CD2 and NKG2D as well as HLA-A2:NY-ESO-1 antibody, we have demonstrated that their known tumor interaction partners, CD58, MICB, and HLA-A respectively, are B3GNT2 target proteins49,50 (Fig. 4c, d).